Joel Greenblatt's AMED Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 342,392 shares of Amedisys, Inc. (AMED) worth $0, representing 0.00% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in AMED, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2015, adding 355,859 shares. Largest reduction occurred in Q3 2015, reducing 258,006 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Amedisys (AMED) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amedisys (AMED) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2014 | +23,349 | New Buy | 23,349 | $29.34 |
| Q1 2015 | +16,185 | Add 69.32% | 39,534 | $26.79 |
| Q2 2015 | +355,859 | Add 900.13% | 395,393 | $39.73 |
| Q3 2015 | -258,006 | Reduce 65.25% | 137,387 | $37.97 |
| Q4 2015 | +208,525 | Add 151.78% | 345,912 | $39.32 |
| Q1 2016 | -116,209 | Reduce 33.59% | 229,703 | $48.34 |
| Q2 2016 | -178,138 | Reduce 77.55% | 51,565 | $50.48 |
| Q3 2016 | -45,627 | Reduce 88.48% | 5,938 | $47.49 |
| Q4 2016 | -5,938 | Sold Out | 5,938 | $0.00 |
| Q3 2017 | +7,248 | New Buy | 7,248 | $56.02 |
| Q4 2017 | +101,470 | Add 1399.97% | 108,718 | $52.71 |
| Q1 2018 | -108,718 | Sold Out | 108,718 | $0.00 |
| Q4 2018 | +6,505 | New Buy | 6,505 | $117.14 |
| Q1 2019 | +3,188 | Add 49.01% | 9,693 | $123.28 |
| Q2 2019 | +6,250 | Add 64.48% | 15,943 | $121.43 |
| Q3 2019 | -9,863 | Reduce 61.86% | 6,080 | $131.09 |
| Q4 2019 | -2,458 | Reduce 40.43% | 3,622 | $167.03 |
| Q2 2020 | -55 | Reduce 1.52% | 3,567 | $198.49 |
| Q1 2021 | +204 | Add 5.72% | 3,771 | $264.92 |
| Q2 2021 | +6,279 | Add 166.51% | 10,050 | $244.98 |
| Q3 2021 | +737 | Add 7.33% | 10,787 | $149.07 |
| Q4 2021 | +381 | Add 3.53% | 11,168 | $161.89 |
| Q1 2022 | +4,516 | Add 40.44% | 15,684 | $172.28 |
| Q2 2022 | +1,604 | Add 10.23% | 17,288 | $105.10 |
| Q3 2022 | +6,035 | Add 34.91% | 23,323 | $96.77 |
| Q4 2022 | -2,297 | Reduce 9.85% | 21,026 | $83.54 |
| Q1 2023 | +11,775 | Add 56.00% | 32,801 | $73.55 |
| Q2 2023 | +38,305 | Add 116.78% | 71,106 | $91.44 |
| Q3 2023 | +4,430 | Add 6.23% | 75,536 | $93.40 |
| Q4 2023 | -9,128 | Reduce 12.08% | 66,408 | $95.06 |
| Q1 2024 | +16,553 | Add 24.93% | 82,961 | $92.16 |
| Q2 2024 | +42,098 | Add 50.74% | 125,059 | $91.80 |
| Q3 2024 | +14,139 | Add 11.31% | 139,198 | $96.51 |
| Q4 2024 | +107,720 | Add 77.39% | 246,918 | $90.79 |
| Q1 2025 | +45,146 | Add 18.28% | 292,064 | $92.63 |
| Q2 2025 | +50,328 | Add 17.23% | 342,392 | $98.39 |
| Q3 2025 | -342,392 | Sold Out | 342,392 | $0.00 |
Joel Greenblatt's Amedisys Investment FAQs
Joel Greenblatt first purchased Amedisys, Inc. (AMED) in Q4 2014, acquiring 23,349 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Amedisys, Inc. (AMED) for 44 quarters since Q4 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to Amedisys, Inc. (AMED) was in Q2 2015, adding 395,393 shares worth $15.71 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 342,392 shares of Amedisys, Inc. (AMED), valued at approximately $0. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Amedisys, Inc. (AMED) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in Amedisys, Inc. (AMED) was 395,393 shares, as reported at the end of Q2 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.